In the recent months we have received many inquiries from USA based pharma and life sciences companies. They plan to access the market in Europe or want to expand their EU business.
To expand or to start business in Europe, there are two important strategic topics:
- Processing personal data according the EU privacy direction (GDPR). This is different from the US and other contintents
- The way EU HCPs want to get in touch with pharma and life sciences companies is moving from only sales reps’ visits to an omni-channel approach.
Do you want to know more about our special services to execute your market access and or expansion? Please contact us!
Pharma – Data – Digital – GDPR
Our company is rapidly growing internationally across the EU in 2021, and works together with several players in the field of pharma, data, digital, GDPR and customer experience.
We strongly believe that organisations that process personal data both responsibly and relevantly are the winners of the future. This is because these organisations build strong and honest relationships by putting people and their data at the heart of what they do.
Individual consent management
By asking individual people about their needs and asking for their consent (opt-in), you let them decide what to do with the data.
Control over personal data
People are more willing to share their data with these types of organisations. These individuals will perceive trust by keeping control over their own personal data. Further, you know what they want and can give them what they want.
What we do
Personal data & e-consent platform
We provide organisations with a state-of-the-art technology solution for relevant and compliant personal data utilisation. We cooperate with our partners—leaders in specific industries.
Powered by OptInsight
Our ambition is that people who share their personal data with organisations that use the OptInsight platform, have full confidence in sharing their preferences and needs
Why we do it
Enabling personal data utilisation
Personal data belongs to the people who share this data with organisations. We believe that the value this data represents should be shared equally, and treated relevantly and responsibly.